ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 108 filers reported holding ADICET BIO INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $457,022 | -42.0% | 333,593 | +2.9% | 0.00% | -40.0% |
| Q2 2023 | $787,699 | -50.6% | 324,156 | +17.1% | 0.01% | -50.0% |
| Q1 2023 | $1,594,155 | +157.0% | 276,763 | +298.9% | 0.01% | +150.0% |
| Q4 2022 | $620,276 | +29.0% | 69,382 | +152.3% | 0.00% | +33.3% |
| Q4 2021 | $481,000 | +122.7% | 27,497 | 0.0% | 0.00% | +200.0% |
| Q3 2021 | $216,000 | -23.7% | 27,497 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $283,000 | -21.4% | 27,497 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $360,000 | -6.7% | 27,497 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $386,000 | +18.0% | 27,497 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $327,000 | – | 27,497 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 728,944 | $998,653 | 0.37% |
| DAFNA Capital Management LLC | 797,054 | $1,091,964 | 0.34% |
| COWEN AND COMPANY, LLC | 2,715,278 | $3,719,930 | 0.26% |
| Orbimed Advisors | 8,322,140 | $11,401,332 | 0.24% |
| TANG CAPITAL MANAGEMENT LLC | 1,226,352 | $1,680,102 | 0.24% |
| Carlyle Group Inc. | 2,115,385 | $2,876,924 | 0.12% |
| RTW INVESTMENTS, LP | 4,241,472 | $5,810,817 | 0.12% |
| Acuitas Investments, LLC | 136,779 | $187,387 | 0.11% |
| Decheng Capital Management III (Cayman), LLC | 200,201 | $274,275 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 142,168 | $195 | 0.02% |